Haleon (LSE:HLN) PB Ratio : 1.82 (As of May. 12, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Haleon PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-12), Haleon's share price is £3.278. Haleon's Book Value per Share for the quarter that ended in Mar. 2024 was £1.80. Hence, Haleon's PB Ratio of today is 1.82.

Good Sign:

Haleon PLC stock PB Ratio (=1.82) is close to 1-year low of 1.73

The historical rank and industry rank for Haleon's PB Ratio or its related term are showing as below:

LSE:HLN' s PB Ratio Range Over the Past 10 Years
Min: 0.85 Med: 1.81 Max: 1.91
Current: 1.82

During the past 5 years, Haleon's highest PB Ratio was 1.91. The lowest was 0.85. And the median was 1.81.

LSE:HLN's PB Ratio is ranked better than
54.29% of 956 companies
in the Drug Manufacturers industry
Industry Median: 2.01 vs LSE:HLN: 1.82

During the past 12 months, Haleon's average Book Value Per Share Growth Rate was 1.70% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -14.00% per year.

During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Haleon was -14.00% per year. The lowest was -15.80% per year. And the median was -14.90% per year.

Back to Basics: PB Ratio

Haleon PB Ratio Historical Data

The historical data trend for Haleon's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon PB Ratio Chart

Haleon Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

PB Ratio

1.85

1.79

Haleon Quarterly Data
	Dec19	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
PB Ratio	Get a 7-Day Free Trial									-	1.81	-	1.79	-

Competitive Comparison of Haleon's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Haleon's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Haleon's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Haleon's PB Ratio distribution charts can be found below:

* The bar in red indicates where Haleon's PB Ratio falls into.

Haleon PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Haleon's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Mar. 2024)
	=	3.278	/	1.798
	=	1.82

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Haleon (LSE:HLN) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Haleon PB Ratio Related Terms

Thank you for viewing the detailed overview of Haleon's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Haleon (LSE:HLN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (LSE:HLN) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

HLNCF:USA HLN:USA HLN1:Mexico HLNl:UK H6D0:Germany

Address

The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY

Website

https://www.haleon.com

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.